Neoantigen reactive T cells correlate with the low mutational burden in hematological malignancies

Leukemia. 2022 Nov;36(11):2734-2738. doi: 10.1038/s41375-022-01705-y. Epub 2022 Oct 8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Neoplasm*
  • CD8-Positive T-Lymphocytes
  • Hematologic Neoplasms* / genetics
  • Humans
  • Immunotherapy
  • Mutation

Substances

  • Antigens, Neoplasm